Reference health
<b>Therapeutic potential of cannabidiol and its underlying mechanisms</b>
77/77 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 77 checked references that resolve
resolves10.1089/can.2015.0012
Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy
resolves10.1038/346561a0
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
resolves10.1126/science.1470919
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
resolves10.1006/bbrc.1995.2437
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
resolves10.1016/j.chembiol.2007.11.006
A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
resolves10.1074/jbc.M111.335273
Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain
resolves10.1021/ja01858a058
Structure of Cannabidiol, a Product Isolated from the Marihuana Extract of Minnesota Wild Hemp. I
resolves10.1615/CritRevNeurobiol.v15.i2.10
Regulation of Cannabinoid CB1 Receptors in the Central Nervous System by Chronic Cannabinoids
resolves10.3389/fnbeh.2011.00057
Effects of endocannabinoid system modulation on cognitive and emotional behavior
resolves10.1038/sj.bjp.0707442
The diverse CB<sub>1</sub>and CB<sub>2</sub>receptor pharmacology of three plant cannabinoids: Δ<sup>9</sup>‐tetrahydrocannabinol, cannabidiol and Δ<sup>9</sup>‐tetrahydrocannabivarin
resolves10.1186/s13075-015-0743-x
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis
resolves10.1038/sj.ijo.0803272
The pharmacology of cannabinoid receptors and their ligands: an overview
resolves10.1016/j.bcp.2008.06.022
The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT)
resolves10.1074/jbc.M111.287649
Heteromultimerization of Cannabinoid CB1 Receptor and Orexin OX1 Receptor Generates a Unique Complex in Which Both Protomers Are Regulated by Orexin A
resolves10.1093/brain/awp239
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
resolves10.1074/jbc.M111.291294
CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling
resolves10.1177/0269881111400652
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity
resolves10.1002/syn.20569
Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus
resolves10.1111/j.1471-4159.2005.03380.x
Modulation of the cannabinoid CB<sub>2</sub> receptor in microglial cells in response to inflammatory stimuli
resolves10.1016/j.smim.2014.04.002
What we know and do not know about the cannabinoid receptor 2 (CB2)
resolves10.1016/S0162-3109(98)00041-1
Δ9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells
resolves10.1016/j.semarthrit.2013.04.008
Role of neuroendocrine and neuroimmune mechanisms in chronic inflammatory rheumatic diseases—The 10-year update
resolves10.1073/pnas.160105897
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
resolves10.1016/j.pbb.2011.06.022
Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice
resolves10.1186/1471-2474-15-275
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
resolves10.1073/pnas.0511232103
Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression
resolves10.1007/978-3-0348-8990-2_3
Membrane Associated L-Glutamate Decarboxylase and Insulin-Dependent Diabetes Mellitus (IDDM)
resolves10.1080/08916930500356674
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice
resolves10.2353/ajpath.2006.050500
Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes
resolves10.1007/s00109-011-0856-x
Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
resolves10.1016/j.phymed.2013.11.006
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol
resolves10.1096/fj.11-198184
Cannabidiol inhibits lung cancer cell invasion and metastasis
<i>via</i>
intercellular adhesion molecule‐1
resolves10.1124/jpet.103.061002
Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines
resolves10.1124/mol.106.023937
Cannabidiol-Induced Apoptosis in Human Leukemia Cells: A Novel Role of Cannabidiol in the Regulation of p22 and Nox4 Expression
resolves10.1124/jpet.106.105247
Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma
resolves10.1038/sj.bjp.0704327
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
resolves10.1038/73171
Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
resolves10.3747/co.23.2893
In Vitro and In Vivo Efficacy of Non-Psychoactive Cannabidiol in Neuroblastoma
resolves10.1186/1476-4598-9-196
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
resolves10.1074/jbc.M603495200
Cannabinoid Receptor Agonist-induced Apoptosis of Human Prostate Cancer Cells LNCaP Proceeds through Sustained Activation of ERK1/2 Leading to G1 Cell Cycle Arrest
resolves10.1161/01.STR.0000163083.59201.34
Cannabidiol Prevents Cerebral Infarction Via a Serotonergic 5-Hydroxytryptamine
<sub>1A</sub>
Receptor–Dependent Mechanism
resolves10.1073/pnas.0409888102
CB
<sub>2</sub>
cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids
resolves10.1073/pnas.92.8.3376
Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.
resolves10.1084/jem.20120242
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
resolves10.1186/1744-8069-6-16
Cannabinoid-Mediated Modulation of Neuropathic Pain and Microglial Accumulation in a Model of Murine Type I Diabetic Peripheral Neuropathic Pain
resolves10.1111/j.1365-2125.2012.04341.x
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
resolves10.1111/bph.12439
Cannabidiol inhibits paclitaxel‐induced neuropathic pain through 5‐<scp>HT<sub>1A</sub></scp> receptors without diminishing nervous system function or chemotherapy efficacy
resolves10.1038/npp.2008.120
Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
resolves10.1016/j.ejphar.2006.11.006
The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain
resolves10.1590/S1516-44462008000300015
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
resolves10.1016/j.physbeh.2005.08.045
Delta-9-tetrahydrocannabinol and cannabidiol, but not ondansetron, interfere with conditioned retching reactions elicited by a lithium-paired context in Suncus murinus: An animal model of anticipatory nausea and vomiting
resolves10.1007/s00213-007-0970-1
The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat
resolves10.1007/s00213-003-1571-2
Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew)
resolves10.1016/S0091-3057(01)00531-7
Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew
resolves10.1002/ptr.5095
Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5Y<i><sup>APP+</sup></i> Cells Through PPARγ Involvement
resolves10.1111/j.1360-0443.1996.tb02264.x
Cannabis: pharmacology and toxicology in animals and humans
resolves10.2174/157488611798280924
Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent
The 2 references without a DOI — listed, not checked
no DOI — not checked38) Dessein PH, Joffe BI, Stanwix AE: Inflammation, insulin resistance, and aberrant lipid metabolism as cardiovascular risk factors in rheumatoid arthritis. J Rheumatol 30: 1403-1405, 2003.
no DOI — not checked70) Ramer R, Hinz B: Effects of cannabinoids on metastasis. In Advances in pharmacology; Cannabinoid Pharmacology. Edited by Kendall D, Alexander S, Academic Press, London, pp414-418, 2017.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.15563/jalliedhealthsci.9.112"><img src="https://citestamp.com/citestamped/10.15563/jalliedhealthsci.9.112/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.15563/jalliedhealthsci.9.112)